| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.22 | 4e-05 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.19 | 0.0004 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0005 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |